Cancer marker test available in London

GeneNews_Col.jpgTORONTO – Biotech firm GeneNews Ltd. broadens access to its ColonSentry genomic technology – a test to determine risk for colorectal cancer – by providing it to three Gamma-Dynacare Medical Laboratories’ patient service centres in London, Ont. Click here for more information.

Submit a comment

Please leave your name, which will be used to sign your submission to the SCANsite. Thanks for contributing your thoughts. Come back again. Tony Patterson, Editor & CEO.

© 2006 - 2009 SCAN
INTEGRITY INTELLIGENCE INFORMATION
Site by Citadel Rock
SCAN